PLX PharmaPLXPQ
13F holders, Q1 2025 (March 31)2holders −1
0new positions
1sold out
$0.00avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding PLX Pharma Inc. (PLXPQ) in their 13F filings, down 1 from Q4 2024. 0 opened new positions and 1 sold out. The largest holders were Financial Gravity Asset Management, Inc. ($0) and O'Brien Greene & Co. Inc ($0).
- Company
- PLX Pharma Inc.
- CUSIP
- 72942A107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 25 shares sold, net −25 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Financial Gravity Asset Management, Inc. | 0.00% | — | 1,050 | $0 |
| O'Brien Greene & Co. Inc | 0.00% | No change | 27,000 | $0 |
"% of holder's portfolio" is PLXPQ's weight in each manager's 13F, not the share of PLX Pharma Inc. the manager owns.